Patient satisfaction with home teleconsultation for ALS care
Satisfaction of Patients With Amyotrophic Lateral Sclerosis Under Non-invasive Ventilation Regarding Home Assisted Teleconsultation
This study is trying to see if patients with ALS are happy with getting their care through home teleconsultations instead of going to the hospital, especially those who use non-invasive ventilation.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | AGIR à Dom Academic / other |
| Locations | 2 sites (Grenoble and 1 other locations) |
| Trial ID | NCT05621213 on ClinicalTrials.gov |
What this trial studies
This study evaluates the satisfaction of patients with amyotrophic lateral sclerosis (ALS) who receive home-assisted teleconsultation for their care, particularly focusing on those using non-invasive ventilation (NIV). Given the progressive nature of ALS and the challenges associated with regular hospital visits, the study aims to explore the feasibility and effectiveness of remote consultations facilitated by healthcare professionals. By utilizing teleconsultation, the study seeks to reduce the burden of hospital visits while ensuring that patients receive adequate monitoring and support for their respiratory needs. The study will assess patient satisfaction and the impact of this approach on their overall care experience.
Who should consider this trial
Good fit: Ideal candidates include ALS patients who are using non-invasive ventilation and have access to the necessary technology for teleconsultation.
Not a fit: Patients who are not compliant with NIV or lack the necessary technology for teleconsultation may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the quality of life for ALS patients by reducing the need for frequent hospital visits.
How similar studies have performed: While telehealth approaches are gaining traction, this specific application for ALS care is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with a diagnosis of ALS coming for a follow-up consultation with their pneumologist * Daily NIV compliance of more than 4 hours in the month prior to inclusion * Living at home * Patient with a natural caregiver * Patient equipped with computer equipment adapted for teleconsultation (tablet, computer, telephone... with an internet connection) * Patient able to read and understand the procedure, and able to express consent for the study protocol * Patient, or his or her caregiver, able to sign the consent to participate by himself or herself Exclusion Criteria: * Patient not available or wishing to change region within 3 months of inclusion * Patient currently participating or having participated in the month prior to inclusion in another clinical interventional research study that may have an impact on the study, this impact is left to the discretion of the investigator * Persons referred to in articles L1121-5 to L1121-8 of the French Public Health Code (corresponding to all protected persons) * Pregnant women (for women of childbearing age and in the absence of reliable contraception, the β-HCG (human chorionic gonadotropin) assay will be performed), parturient women, breastfeeding women, * persons deprived of their liberty by judicial or administrative decision, * persons under legal protection
Where this trial is running
Grenoble and 1 other locations
- CHU Grenoble Alpes — Grenoble, France (Recruiting)
- CHU Montpellier — Montpellier, France (Recruiting)
Study contacts
- Principal investigator: Christel Saint-Raymond, PhD — CHU Grenoble Alpes
- Study coordinator: Céline Barra
- Email: c.barra@agiradom.com
- Phone: 0750543238
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.